Other · developed by Pulmatrix
RUT058-60 is an agent administered as intra-abdominal (peritoneal) lavage before closure of the abdomen at the end of surgical repair. It is studied for the prevention or treatment of deep postoperative wound infection.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02280395 | Phase 1/2 | Postoperative Wound Infection-deep | Terminated | PULM |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Post Operative Wound InfectionPostoperative Wound Infection-deep
Updated Oct 25, 2026. Something wrong or missing? Report it on the PULM page.
See PULM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PULM catalysts and pipeline →